shieldtherapeutics.com LSE:STX - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

We are thrilled to officially welcome our new colleagues from Viatris Inc. to the Shield family. You are joining us at an incredibly exciting moment. We look forward to seeing what we will achieve together! shieldtherapeutics.com shieldtherapeutics.com/annou…

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Shield Therapeutics hosted an investor webinar on assuming full control of ACCRUFeR® in the US. CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert presented an update, followed by a live Q&A. 🎥 Watch the recording: shieldtherapeutics.com/webin…

We're excited to announce that Michael Jensen will be joining Shield Therapeutics as Chief Financial Officer today. Please join us in giving Michael a warm welcome to the team!

📢 Today at 2:15 pm (BST): Shield Therapeutics present the latest update which announced that Shield will assume full commercial responsibility for ACCRUFeR® in the US. Still time to register 👇 shieldtherapeutics.com/webin…

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Interim results for the six months ended 30 Jun 26 Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Shield Therapeutics Q2/H1 2026 Trading Update webinar is now live. Hear from management on the latest commercial progress, financial highlights, and outlook for the year ahead, followed by a live Q&A with investors. 🎥 Watch here: shieldtherapeutics.com/webin…

📢 Today at 2:15pm (BST) - our Q2/H1 2026 Trading Update webinar. CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert, Sr Director FP&A, will present our Q2/H1 2026 Trading Update and take questions live from shareholders. Still time to register 👇 shieldtherapeutics.com/webin…

We've just released the following announcement: Shield Therapeutics - Q2 and H1 2026 Trading Update Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - ACCRUFeR® Phase 3 pediatric trial published Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Wishing all of our team, partners, and investors across the US a very Happy Independence Day. Today is a great reminder of the values that inspire progress and the determination to keep building something better. Enjoy the long weekend, and have a safe and wonderful 4th of July

We've just released the following announcement: Shield Therapeutics - Block Listing 6 Monthly Return Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Results of 2026 Annual General Meeting Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Today, we mark International Nurses Day, celebrated each year on the birthday of Florence Nightingale to honour the vital contribution nurses make to healthcare worldwide. #InternationalNursesDay #NursingMatters #Healthcare #NHS #ThankYouNurses

Shield Therapeutics Q1 2026 Trading Update webinar is now live. Hear from management on ACCRUFeR® growth and what’s next. 🎥 Watch here: shieldtherapeutics.com/activ…